3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
2429
Neoplasms
1840
Carcinoma, Non-Small-Cell Lung
1615
Prostatic Neoplasms
1309
Colorectal Neoplasms
1147
Lung Neoplasms
991
Neoplasm Metastasis
836
Multiple Myeloma
801
Leukemia, Myeloid, Acute
777
Ovarian Neoplasms
682
Pancreatic Neoplasms
667
Melanoma
667
Squamous Cell Carcinoma of Head and Neck
592
Recurrence
568
Carcinoma, Hepatocellular
568
Brain Neoplasms
529
Glioblastoma
519
Stomach Neoplasms
504
Head and Neck Neoplasms
503
Triple Negative Breast Neoplasms
472
Lymphoma
462
Uterine Cervical Neoplasms
454
Carcinoma, Renal Cell
429
Precursor Cell Lymphoblastic Leukemia-Lymphoma
419
Lymphoma, Non-Hodgkin
392
Endometrial Neoplasms
385
Sarcoma
370
Lymphoma, Follicular
358
Urinary Bladder Neoplasms
356
Lymphoma, Large B-Cell, Diffuse
355
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Chickenpox
×
1 year
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled